Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MES-1022 by Mesentech for Bone Fracture: Likelihood of Approval
MES-1022 is under clinical development by Mesentech and currently in Phase I for Bone Fracture. According to GlobalData, Phase I...